Skip to content

Effect of narrative nursing combined with cognitive behavioral rehabilitation on cognitive function and anxiety in patients with Alzheimer's disease

Effect of narrative nursing combined with cognitive behavioral rehabilitation on cognitive function and anxiety in patients with Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10742199
Enrollment
172
Registered
2025-03-27
Start date
2020-01-10
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nursing care for patients with Alzheimers disease Nervous System Diseases

Interventions

Patients with AD were selected using a random sampling method and divided equally into the observation group and the control group using a random number table. Patients in the control group received c

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria of AD in the 2018 Chinese guidelines for the diagnosis and treatment of dementia and cognitive impairment (II): Guidelines for the diagnosis and treatment of Alzheimer’s disease 2. Basic language ability for simple communication 3. Meets the requirements of medical ethics in our hospital, and their family members signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. Severe psychiatric disorders that would prevent participation in cognitive behavioral therapy 2. Acute or unstable cardiovascular conditions requiring intensive medical management 3. Severe cognitive impairment (Mini-Mental State Examination [MMSE] score =10) that would preclude meaningful participation in the intervention

Design outcomes

Primary

MeasureTime frame
The following primary outcome measures are assessed at baseline and 6 months: 1. Cognitive functions measured using Chinese versions of the MMSE and Montreal Cognitive Assessment (MoCA) 2. Anxiety measured using the Generalised Anxiety Disorder-7 (GAD-7) scale 3. Activities of Daily Living (ADLs) and quality of life (QoL) measured using the Alzheimer’s Disease Cooperative Study (ADCS)-ADL and Quality of Life in Alzheimer’s Disease (QoL-AD) scales

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

China

Contacts

Public ContactDai Li
lidai_2024@126.com+8602260363844

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026